source
- Electra Therapeutics raises $350 million in Nasdaq IPO to fund commercial expansionElectra Therapeutics announced that it priced its initial public offering on the Nasdaq at $350 million, becoming the 21st biotech to go public in 2026. The Bay Area‑based company said the capital…
- Electra Therapeutics raises $350M in biotech IPO, fueling rare disease drug developmentElectra Therapeutics completed a $350 million initial public offering, becoming the 21st biotechnology company to go public in 2026. The strong demand for its shares highlights continued investor a…